CY1119857T1 - Ενδιαμεσα αγομελατινης και μεθοδος παρασκευης αυτων - Google Patents

Ενδιαμεσα αγομελατινης και μεθοδος παρασκευης αυτων

Info

Publication number
CY1119857T1
CY1119857T1 CY20181100076T CY181100076T CY1119857T1 CY 1119857 T1 CY1119857 T1 CY 1119857T1 CY 20181100076 T CY20181100076 T CY 20181100076T CY 181100076 T CY181100076 T CY 181100076T CY 1119857 T1 CY1119857 T1 CY 1119857T1
Authority
CY
Cyprus
Prior art keywords
intermediates
agomelatin
preparing
preparation
methods
Prior art date
Application number
CY20181100076T
Other languages
English (en)
Inventor
Peng Zhang
Yu Huang
Zhedong Yuan
Hanbin Shan
Xiong Yu
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45097542&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1119857(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of CY1119857T1 publication Critical patent/CY1119857T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/06Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Battery Electrode And Active Subsutance (AREA)

Abstract

Παρέχονται ενδιάμεσες ενώσεις για παρασκευή αγομελατίνης και μέθοδοι παρασκευής αυτών. Επίσης παρέχονται δύο νέες ενδιάμεσες ενώσεις. Η μέθοδος είναι απλή στον χειρισμό, καλά ελεγχόμενη, κατάλληλη για βιομηχανική παραγωγή και έχει υψηλή καθαρότητα, χωρίς περίπλοκες διαδικασίες όπως διαχωρισμό με κλασματική απόσταξη και χρωματογραφία στήλης. Εν τω μεταξύ, οι μέθοδοι παρασκευής των δύο νέων ενδιαμέσων είναι από μόνες τους απλές και έχουν υψηλή απόδοση.
CY20181100076T 2010-06-08 2018-01-22 Ενδιαμεσα αγομελατινης και μεθοδος παρασκευης αυτων CY1119857T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2010101973700A CN102276492B (zh) 2010-06-08 2010-06-08 阿戈美拉汀中间体及其制备方法
PCT/CN2011/075438 WO2011153939A1 (en) 2010-06-08 2011-06-08 Agomelatine intermediates and preparation method thereof

Publications (1)

Publication Number Publication Date
CY1119857T1 true CY1119857T1 (el) 2018-06-27

Family

ID=45097542

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100076T CY1119857T1 (el) 2010-06-08 2018-01-22 Ενδιαμεσα αγομελατινης και μεθοδος παρασκευης αυτων

Country Status (40)

Country Link
US (1) US8779199B2 (el)
EP (1) EP2580189B1 (el)
JP (1) JP5519863B2 (el)
KR (1) KR101470874B1 (el)
CN (1) CN102276492B (el)
AP (1) AP3205A (el)
AU (1) AU2011264206B2 (el)
BR (1) BR112012031086B1 (el)
CA (1) CA2801822C (el)
CL (1) CL2012003371A1 (el)
CR (1) CR20120592A (el)
CU (1) CU24148B1 (el)
CY (1) CY1119857T1 (el)
DK (1) DK2580189T3 (el)
EA (1) EA020271B1 (el)
EC (1) ECSP12012328A (el)
ES (1) ES2656968T3 (el)
GE (1) GEP20156234B (el)
GT (1) GT201200328A (el)
HR (1) HRP20171751T1 (el)
HU (1) HUE035850T2 (el)
IL (1) IL223180A (el)
LT (1) LT2580189T (el)
MA (1) MA34292B1 (el)
ME (1) ME02992B (el)
MX (1) MX2012013870A (el)
MY (1) MY160954A (el)
NI (1) NI201200177A (el)
NO (1) NO2580189T3 (el)
NZ (1) NZ604081A (el)
PE (1) PE20130252A1 (el)
PL (1) PL2580189T3 (el)
PT (1) PT2580189T (el)
RS (1) RS56659B1 (el)
SG (1) SG185667A1 (el)
SI (1) SI2580189T1 (el)
TN (1) TN2012000542A1 (el)
UA (1) UA104684C2 (el)
WO (1) WO2011153939A1 (el)
ZA (1) ZA201208764B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
CN102452951B (zh) * 2010-10-25 2014-02-19 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
WO2014056421A1 (zh) * 2012-10-09 2014-04-17 江西同和药业有限责任公司 1-氰基-1-(7-甲氧基-1-萘基)甲醇酯类化合物及其制备方法和应用
CN112574066A (zh) * 2019-09-27 2021-03-30 江苏豪森药业集团有限公司 一种阿戈美拉汀中间体的制备方法
EP4081505A1 (en) * 2019-12-23 2022-11-02 DSM IP Assets B.V. Dehydrogenation process

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2866336B1 (fr) * 2004-02-13 2006-03-24 Servier Lab Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine
FR2866334B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
WO2007147771A2 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101486665B (zh) * 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法
EP2705023A4 (en) * 2011-01-04 2014-11-19 Symed Labs Ltd PROCESSES FOR THE PREPARATION OF N- [2- (7-METHOXY-1-NAPHTHYLLELYHYL) ACETAMIDE

Also Published As

Publication number Publication date
SG185667A1 (en) 2012-12-28
UA104684C2 (ru) 2014-02-25
EA201201666A1 (ru) 2013-05-30
CL2012003371A1 (es) 2013-03-22
GT201200328A (es) 2014-06-09
AU2011264206B2 (en) 2013-08-15
ECSP12012328A (es) 2012-12-28
NO2580189T3 (el) 2018-03-24
AP3205A (en) 2015-03-31
MY160954A (en) 2017-03-31
RS56659B1 (sr) 2018-03-30
US8779199B2 (en) 2014-07-15
IL223180A0 (en) 2013-02-03
ES2656968T3 (es) 2018-03-01
CU24148B1 (es) 2016-02-29
CN102276492B (zh) 2013-04-10
CR20120592A (es) 2013-03-04
MX2012013870A (es) 2013-01-24
CA2801822C (en) 2015-03-24
CU20120163A7 (es) 2013-01-30
HUE035850T2 (en) 2018-05-28
AP2013006659A0 (en) 2013-01-31
EP2580189A1 (en) 2013-04-17
PT2580189T (pt) 2017-12-06
US20130267738A1 (en) 2013-10-10
BR112012031086A2 (pt) 2017-06-20
TN2012000542A1 (en) 2014-04-01
KR20130028134A (ko) 2013-03-18
PL2580189T3 (pl) 2018-04-30
AU2011264206A1 (en) 2012-12-13
PE20130252A1 (es) 2013-03-16
JP5519863B2 (ja) 2014-06-11
CA2801822A1 (en) 2011-12-15
ME02992B (me) 2018-10-20
LT2580189T (lt) 2017-12-11
MA34292B1 (fr) 2013-06-01
CN102276492A (zh) 2011-12-14
HRP20171751T1 (hr) 2017-12-29
EP2580189A4 (en) 2016-01-06
IL223180A (en) 2014-06-30
NZ604081A (en) 2014-01-31
EP2580189B1 (en) 2017-10-25
WO2011153939A1 (en) 2011-12-15
DK2580189T3 (da) 2018-01-29
ZA201208764B (en) 2014-01-29
NI201200177A (es) 2013-02-06
BR112012031086B1 (pt) 2020-12-08
JP2013531639A (ja) 2013-08-08
GEP20156234B (en) 2015-01-26
EA020271B1 (ru) 2014-09-30
SI2580189T1 (en) 2018-01-31
KR101470874B1 (ko) 2014-12-09

Similar Documents

Publication Publication Date Title
CY1119857T1 (el) Ενδιαμεσα αγομελατινης και μεθοδος παρασκευης αυτων
CY1120660T1 (el) Καινοφανεις υποκαταστατες toy rig-i και μεθοδοι παραγωγης αυτων
CO7141403A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
CO7141404A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
CY1119370T1 (el) Μεθοδος για την παρασκευη τρεπτοστινιλης και παραγωγων αυτης
BR112013016863A2 (pt) processo para produzir um polistereterol
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
MX2019005319A (es) Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo.
EA201391721A1 (ru) Способ получения полиморфной формы i эторикоксиба
EA201500648A1 (ru) (6r,10r)-6,10,14-триметилпентадекан-2-он, получаемый из 6,10-диметилундец-5-ен-2-она или 6,10-диметилундека-5,9-диен-2-она
MX2016014119A (es) Proceso para preparar cicloserinas sustituidas.
BR112017017066A2 (pt) método de preparação para praziquantel e compostos intermediários do mesmo
MX2016006558A (es) Sistesis de trans-8-cloro-5-metil-1-[4-(piridin-2-iloxi)-ciclohexi l]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azuleno y formas cristalinas del mismo.
CO7141402A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
EA201590116A1 (ru) Способ получения замещенных триазолопиридинов
SA515370303B1 (ar) جسيم سيليكا معدلة
EA200870320A1 (ru) Способ получения г-ксф человека
CO6771436A2 (es) Método de preparación de nueva medicina antibacterialde polipéptido recombinante
EA201291486A1 (ru) Получение тезетакселя и родственных соединений и соответствующего промежуточного продукта синтеза
IN2014CH01392A (el)
WO2015188243A9 (en) PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
CY1118121T1 (el) Διαδικασια για την παραγωγη ιβαμπραδινης και ενδιαμεσων της συνθεσης αυτης
CO6592020A2 (es) Intemedios de agomelatina y método de preparación de éstos
MX2012013730A (es) Sintesis por electrocarboxilacion para obtener intermedios utiles para la sintesis de derivados de span.